VALEUPROX ®Depot (Leuprolide Acetate Depot)

VALEUPROX® Depot (Leuprolide Acetate Depot): 3.75 mg & 11.25 mg Injections.

Basic Product Specification:

Generic Name Strength Standard Type Packing
Leuprolide Acetate 3.75 / 11.25 mg Depot. USP SC/IM Injection 1 ml Solvent + Powder Vial in a Combipack
    • VALEUPROX®Depot contains Leuprolide Acetate Depot Injections.
    • VALEUPROX®Depot comes under the category of a GnRH/ LHRH Agonist.
    • VALEUPROX®Depot forms a cloudy liquid on reconstitution.
    • VALEUPROX®Depot is indicated for specific treatment of Central Precocious Puberty in children by Endocrinologists.
    • VALEUPROX®Depot 3.75 injection is recommended once in 28 days, while VALEUPROX®Depot 11.25 is recommended once in 84 days.
    • VALEUPROX®Depot shows Improvement in treated symptoms usually after 3-6 months of initiation of treatment.
    • Once the solvent ampoule & powder vial of VALEUPROX®Depot is reconstituted, it should be injected quickly within 30 minutes or else it will have to be discarded.